In 22 of 133 patients with COVID-19, positive sputum, fecal samples seen after negative pharyngeal sample.
10-year cumulative incidence of biochemical and/or clinical disease failure no different with C-, H-IMRT.
An understanding of the tumor methylome can provide information on gene regulation in different cancers.
The Centers for Disease Control and Prevention (CDC) released preliminary data related to outcomes among US patients with coronavirus disease 2019 (COVID-19).
MRI-guided confirmatory prostate biopsies more accurately detects grade progression among men on active surveillance for prostate cancer compared with TRUS-guided systematic biopsies alone.
Erectile function improved significantly among men with ED in the placebo arms of clinical trials of phosphodiesterase 5 inhibitors, especially among those with posttraumatic stress disorder, a meta-analysis revealed.
The FDA has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).
In a small study, pancytopenia induced by radium-223—which is used to treat bone metastases in men with metastatic castration-resistant prostate cancer— developed more frequently reported in the pivotal phase 3 trial of the drug.
Highly effective contact tracing and isolation may be viable containment strategies for a COVID-19.
The authors of new review say the results of the JCOG0401 trial suggest that standard hormonal therapy alone vs salvage radiotherapy is not an appropriate management strategy for recurrence after radical prostatectomy.